Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-25-013548
Filing Date
2025-04-29
Accepted
2025-04-29 16:32:22
Documents
21
Period of Report
2025-06-20

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A dyai20241114_def14a.htm   iXBRL DEF 14A 643807
6 graph001.jpg GRAPHIC 52409
7 i01.jpg GRAPHIC 132134
8 i02.jpg GRAPHIC 81675
9 logodyadic01.jpg GRAPHIC 6520
10 logomedium.jpg GRAPHIC 7252
  Complete submission text file 0001437749-25-013548.txt   1845610

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dyai-20241231.xsd EX-101.SCH 4863
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20241231_def.xml EX-101.DEF 2241
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20241231_lab.xml EX-101.LAB 2602
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20241231_pre.xml EX-101.PRE 1439
24 EXTRACTED XBRL INSTANCE DOCUMENT dyai20241114_def14a_htm.xml XML 64826
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32513 | Film No.: 25888315
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)